Rhythm Pharmaceuticals (NASDAQ:RYTM) Given “Market Outperform” Rating at JMP Securities
Rhythm Pharmaceuticals (NASDAQ:RYTM – Get Free Report)‘s stock had its “market outperform” rating restated by stock analysts at JMP Securities in a research note issued on Monday,Benzinga reports. They presently have a $75.00 target price on the stock. JMP Securities’ price target suggests a potential upside of 33.64% from the stock’s current price. Several other […]
More Stories
30-Year Fixed-Rate Mortgage Rate Hits 7.4 percent
By Naveen Athrappully The average weekly rate on a 30-year fixed-rate mortgage hit 7.4 percent, according to a Oct. 8...
US Issues Security Alert to Citizens in Middle East After Houthis Attack Saudi Arabia
By Aldgra Fredly The United States warned American citizens in the Middle East to remain vigilant on Thursday after Yemen’s...
Americans’ Incomes, Net Worth Climbed in Post-Pandemic Years: Federal Reserve
By Andrew Moran Americans’ incomes and net worth rose in the years after the pandemic, the Federal Reserve said in...
Judge Bars Deportation of Illegal Immigrant Shot by ICE in New York
By Aldgra Fredly A federal judge barred the Trump administration from deporting a Dominican immigrant who was shot by a...
‘It’s Time for Ukraine to Get a New President,’ Trump Says
By Timothy Frudd U.S. President Donald Trump suggested on Oct. 10 that Ukraine needs a new leader, one day after...
UAE Prosecutor Says Flydubai Co-Pilot Drifted Toward Extremism While in Australia
By Aldgra Fredly The co-pilot who allegedly attempted to hijack a Flydubai flight on Sept. 30 drifted toward extremism and...